Phocas Financial Corp. Ptc Therapeutics, Inc. Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$22.41 - $41.99 $358,470 - $671,672	-15,996 Reduced 19.82%	64,701 $1.45 Million
Q2 2023 Jul 12, 2023	SELL	$40.4 - $59.1 $856,601 - $1.25 Million	-21,203 Reduced 20.81%	80,697 $3.28 Million
Q1 2023 Apr 13, 2023	BUY	$38.16 - $48.86 $1.22 Million - $1.57 Million	32,035 Added 45.85%	101,900 $4.94 Million
Q4 2022 Jan 10, 2023	SELL	$33.53 - $54.79 $2,380 - $3,890	-71 Reduced 0.1%	69,865 $0
Q3 2022 Oct 14, 2022	BUY	$41.85 - $53.85 $2.93 Million - $3.77 Million	69,936 New	69,936 $3.51 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.